MedTrace Logo

Viral Triggers in Pediatric Lung Transplantation

NCT00891865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2020-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether respiratory viral infections increase the risk of bronchiolitis obliterans syndrome (BOS), obliterative bronchiolitis (OB), death, or retransplantation in children who have received lung transplants.

Conditions

  • Lung Transplant
  • Bronchiolitis Obliterans
  • Obliterative Bronchiolitis

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Stuart Sweet, MD, PhD · Washington University School of Medicine

  • Lara Danziger-Isakov, MD, MPH · Children's Hospital Medical Center, Cincinnati

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00891865 on ClinicalTrials.gov